Tags: glaucoma | drug | lowers | eye | pressure | fda

Glaucoma Drug Lowers Eye Pressure: FDA Review

Image: Glaucoma Drug Lowers Eye Pressure: FDA Review
Copyright iStock)

Thursday, 12 Oct 2017 09:29 AM

Aerie Pharmaceuticals Inc's experimental glaucoma treatment Rhopressa is effective in lowering eye pressure, a preliminary review by the U.S. Food and Drug Administration concluded.

The review, posted on Wednesday on the FDA's website, comes two days ahead of a meeting of outside experts who will advise the agency on whether the treatment should be approved.

Glaucoma, a condition caused by damage to the optic nerve, is the second-leading cause of blindness in the world. It is expected to affect more than 4 million Americans by 2030, up from 2.7 million today.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
Aerie Pharmaceuticals Inc's experimental glaucoma treatment Rhopressa is effective in lowering eye pressure, a preliminary review by the U.S. Food and Drug Administration concluded.The review, posted on Wednesday on the FDA's website, comes two days ahead of a meeting of...
glaucoma, drug, lowers, eye, pressure, fda
91
2017-29-12
Thursday, 12 Oct 2017 09:29 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved